Several clinical studies have indicated that circulating adiponectin levels are decreased in patients with insulin resistance, type 2 diabetes mellitus, and obesity [38,39]. The gene discussed is ADIPOQ; the disease is obesity due to melanocortin 4 receptor deficiency.